Program
CEA-targeted CAR-T cells
Its studies are mostly in Stomach Neoplasms · Lung Neoplasms · Colorectal Neoplasms, led by Chongqing Precision Biotech.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Chongqing Precision Biotech | 54 open or running | phase 2since Sep 9, 2022 | Sep 9, 2022 | Dec 31, 2026phase 1 · NCT06043466 |
Also a collaborator on its studies: First Affiliated Hospital of Wannan Medical College.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Sep 9, 2022First study: phase 2 study in Stomach NeoplasmsFirst studyNCT05538195 · 17 enrolled · China
- Aug 17, 2023Phase 2 study in Stomach NeoplasmsNCT06006390 · 60 planned · China
- Sep 5, 2023Phase 1 study in Colorectal NeoplasmsNCT06043466 · 30 planned · China
- Nov 6, 2023Phase 1 study in Stomach NeoplasmsNCT06126406 · 60 planned · China
- Sep 11, 2025Phase 1 study in Lung NeoplasmsNCT07179692 · 108 planned · China
Ahead
- Dec 31, 2026Primary completion: phase 1 study in Colorectal NeoplasmsNCT06043466
- Mar 31, 2028Primary completion: phase 1 study in Lung NeoplasmsNCT07179692
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 5 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07179692Lung Neoplasms · China | 1 | Recruiting | Mar 31, 2028 | 108 |
| NCT06126406Stomach Neoplasms · China | 1 | Recruiting | Dec 31, 2025 | 60 |
| NCT06043466Colorectal Neoplasms · China | 1 | Recruiting | Dec 31, 2026 | 30 |
| NCT06006390Stomach Neoplasms · China | 2 | Recruiting | Dec 31, 2025 | 60 |
| NCT05538195Stomach Neoplasms · China | 2 | Completed | Dec 30, 2023 | 17 |
How it is read
Names in the registry
- “CEA-targeted CAR-T cells”, 10 entries
Conditions, from the studies’ own filings
- Stomach Neoplasms, 3 studies
- Lung Neoplasms, 1 study
- Colorectal Neoplasms, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.